Impact of age and SARS-CoV-2 breakthrough infection on humoral immune responses after three doses of COVID-19 mRNA vaccine

Francis Mwimanzi, Hope R. Lapointe, Peter K. Cheung, Yurou Sang, Fatima Yaseen, Rebecca Kalikawe, Sneha Datwani, Laura Burns, Landon Young, Victor Leung, Siobhan Ennis, Chanson J. Brumme, Julio S.G. Montaner, Winnie Dong, Natalie Prystajecky, Christopher F. Lowe, Mari L. DeMarco, Daniel T. Holmes, Janet Simons, Masahiro Niikura, Marc G. Romney, Zabrina L. Brumme, Mark A. Brockman
doi: https://doi.org/10.1101/2022.08.08.22278494

Data Availability

All data produced in the present study are available upon reasonable request to the authors. Upon study conclusion, data will also be deposited into a national database managed by the funder (CITF). Viral sequences are deposited into GISAID

Back to top
Posted October 04, 2022.
Download PDF
Data/Code
Email
Impact of age and SARS-CoV-2 breakthrough infection on humoral immune responses after three doses of COVID-19 mRNA vaccine
Francis Mwimanzi, Hope R. Lapointe, Peter K. Cheung, Yurou Sang, Fatima Yaseen, Rebecca Kalikawe, Sneha Datwani, Laura Burns, Landon Young, Victor Leung, Siobhan Ennis, Chanson J. Brumme, Julio S.G. Montaner, Winnie Dong, Natalie Prystajecky, Christopher F. Lowe, Mari L. DeMarco, Daniel T. Holmes, Janet Simons, Masahiro Niikura, Marc G. Romney, Zabrina L. Brumme, Mark A. Brockman
medRxiv 2022.08.08.22278494; doi: https://doi.org/10.1101/2022.08.08.22278494
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area